Skip to main content


The Center for Population-Level Bioethics (CPLB) is dedicated to the study of macro-level bioethical dilemmas: those that arise outside the clinical encounter, at the level of the population, the state, the country, or the globe. Questions of interest range from the theoretical to the applied, for example how to conceptualize, measure and evaluate health inequalities or disease severity; how to prioritize resources between disease areas, rural and urban patients, and age cohorts or generations; the acceptability of paternalistic health promotion measures; and many others.

Learn More Give


CPLB/IFH team provides ethical advice to GiveWell

8 July 2024

GiveWell is a nonprofit that aims to find charitable giving opportunities that help donors do as much good as possible with their donations...

Read More

Daniel Hausman’s article to be published in PharmacoEconomics

5 July 2024

Daniel Hausman’s essay, "Proxy Preferences and the Values of Children’s Health States", has been accepted for publication by PharmacoEconomics, a leading health-economics journal...

Read More

An article and funding on “Dual-use research and research using enhanced pathogens in high-income countries: whose business?"

28 June 2024

In a new opinion piece in the American Society of Microbiology (ASM) journal mSphere, CPLB director Nir Eyal, senior Tanzanian doctor Melkizedeck Leshabari...

Read More

VIDEO: The Ethical Imperative: Global Vaccine Equity

12 May 2021

On May 12, 2021 the Center for Population-Level Bioethics and co-sponsors 1Day Sooner and the Institute for Health hosted experts for a discussion of vaccine availability around the world, and to launch an open letter to the World Health Organization asking it to put several vaccine measures up to a vote in its upcoming World Health Assembly. The letter was led by veterans of the response to the 2014 Ebola outbreak.

Read More